Endocrinology care
Auth57 · Specialty PA Pack

Endocrinology

For the endocrinologist on GLP-1s, insulin, and growth hormone — where PA bites, and exactly how to clear it.

Structured rules
1,583
PA-required
81%
Appeal layer
51/51
Criteria docs
50/51
The breadth · all 51 jurisdictions

Every state, quantified for endocrinology

StateApproved · CY25RulesPA-requiredAppealCriteria docs
● Recent · CY2025 disclosures — click a state to drill in
WAWashington▸ viewing88.2%3678%11
COColorado91.8%3379%6
OHOhio77.7%3681%15
All states · A–Z
AKAlaska2186%4
ALAlabama3382%6
ARArkansas3681%8
AZArizona3382%5
CACalifornia3678%11
CTConnecticut3379%11
DCDistrict of Columbia3379%8
DEDelaware3382%4
FLFlorida3382%4
GAGeorgia3678%20
HIHawaii3376%9
IAIowa3382%13
IDIdaho2479%10
ILIllinois3281%2
INIndiana3382%8
KSKansas3382%11
KYKentucky3678%4
LALouisiana3083%17
MAMassachusetts2781%14
MDMaryland3080%22
MEMaine3080%4
MIMichigan3083%13
MNMinnesota2483%2
MOMissouri3879%5
MSMississippi3681%9
MTMontana2483%4
NCNorth Carolina3681%31
NDNorth Dakota2483%8
NENebraska3083%4
NHNew Hampshire3083%
NJNew Jersey3080%3
NMNew Mexico2475%5
NVNevada2979%22
NYNew York3379%9
OKOklahoma3681%3
OROregon3681%3
PAPennsylvania3080%23
RIRhode Island2483%3
SCSouth Carolina3281%6
SDSouth Dakota2181%3
TNTennessee3382%6
TXTexas3681%54
UTUtah3382%16
VAVirginia3678%20
VTVermont2181%8
WIWisconsin3382%2
WVWest Virginia2785%2
WYWyoming2483%9
Deep dive· Washington

Washingtonendocrinology, every program

Click any state in the table above to drill into its rules, approval rates, and appeal path.

● Rules verified as-of Jun 8, 2026
Medicaid FFS · CY25
54.8%approved
Draft · aggregatedSource ↗Dental = ~78% of HCA fee-for-service PA volume and is dental-skewed; expedited EPAs aren't captured. Not representative of drug/medical PA. CY2025 data is preliminary.
Medicaid MCO · CY25
88.2%approved · 4 payers
Draft · aggregatedSource ↗
medicaid ffs
Approved · CMS-0057-F 202554.8%
Draft · aggregatedSource ↗Dental = ~78% of HCA fee-for-service PA volume and is dental-skewed; expedited EPAs aren't captured. Not representative of drug/medical PA. CY2025 data is preliminary.
  • growth hormonePA required

    WA Medicaid PDL: non-preferred agents in this class require PA.

  • glp1 agonistsPA required

    WA Medicaid PDL: non-preferred agents in this class require PA.

  • insulinsPA required

    WA Medicaid PDL: non-preferred agents in this class require PA.

commercial regulated
  • insulins(UnitedHealthcare)PA required

    UnitedHealthcare commercial (Advantage 3-Tier). Diabetes-Insulin; almost all QL only, but NOVOLIN R FLEXPEN carries ST; no true PA [e.g. HUMALOG, HUMULIN, LANTUS, insulin lispro]

  • glp1 agonists(UnitedHealthcare)PA required

    UnitedHealthcare commercial (Advantage 3-Tier). GLP-1 (and GLP-1/GIP) agonists within Diabetes-Non-insulin; all carry PA+QL [e.g. OZEMPIC, MOUNJARO, TRULICITY, RYBELSUS]

  • growth hormone(UnitedHealthcare)PA required

    UnitedHealthcare commercial (Advantage 3-Tier). Hormonal-Other; growth hormones (NGENLA, NORDITROPIN, OMNITROPE, SKYTROFA) and GnRH agents (ORIAHNN, ORILISSA) all carry PA+QL(+SP) [e.g. NGENLA, NORDITROPIN FLEXPRO, OMNITROPE, SKYTROFA]

  • insulins(Cigna)No PA

    Cigna commercial (Advantage 3-Tier). insulins open, QL only [e.g. LANTUS, HUMALOG, TRESIBA, INSULIN LISPRO]

  • growth hormone(Cigna)PA required

    Cigna commercial (Advantage 3-Tier). somatropins SP+PA in hormonal agents section [e.g. GENOTROPIN, OMNITROPE, NGENLA, NorditropI]

  • glp1 agonists(Cigna)PA required

    Cigna commercial (Advantage 3-Tier). GLP-1 agonists carry PA+QL [e.g. OZEMPIC, MOUNJARO, TRULICITY, RYBELSUS]

  • insulins(Aetna (CVS Caremark))No PA

    Aetna (CVS Caremark) commercial formulary. insulins, preferred brands; ST/formulary-preferred [e.g. insulin glargine, insulin lispro, insulin aspart, HUMALOG]

  • growth hormone(Aetna (CVS Caremark))PA required

    Aetna (CVS Caremark) commercial formulary. human growth hormones, specialty PA [e.g. somatropin (NORDITROPIN, GENOTROPIN, HUMATROPE)]

  • glp1 agonists(Aetna (CVS Caremark))PA required

    Aetna (CVS Caremark) commercial formulary. incretin mimetic agents + combos, PA/ST (diabetes indication edits) [e.g. OZEMPIC, MOUNJARO, TRULICITY, RYBELSUS]

  • glp1 agonists(Anthem Blue Cross (Elevance))PA required

    Anthem Blue Cross (Elevance) commercial formulary. Incretin mimetic GLP-1 receptor agonists: PA + QL [e.g. liraglutide, dulaglutide, exenatide]

  • insulins(Anthem Blue Cross (Elevance))PA required

    Anthem Blue Cross (Elevance) commercial formulary. Human insulin subclass carries PA + QL in this listing [e.g. HUMALOG, insulin lispro, insulin (human)]

  • growth hormone(Anthem Blue Cross (Elevance))PA required

    Anthem Blue Cross (Elevance) commercial formulary. Growth hormones: PA + SP (some ST) [e.g. OMNITROPE somatropin, growth hormones]

part d
  • growth hormone(Centene)PA required

    Centene Part D (CMS formulary file, plan-grounded).

  • glp1 agonists(Centene)PA required

    Centene Part D (CMS formulary file, plan-grounded).

  • insulins(Centene)No PA

    Centene Part D (CMS formulary file, plan-grounded).

  • growth hormone(Unitedhealthcare)PA required

    Unitedhealthcare Part D (CMS formulary file, plan-grounded).

  • insulins(Unitedhealthcare)No PA

    Unitedhealthcare Part D (CMS formulary file, plan-grounded).

  • glp1 agonists(Unitedhealthcare)PA required

    Unitedhealthcare Part D (CMS formulary file, plan-grounded).

  • insulins(Humana)No PA

    Humana Part D (CMS formulary file, plan-grounded).

  • glp1 agonists(Humana)PA required

    Humana Part D (CMS formulary file, plan-grounded).

  • growth hormone(Humana)PA required

    Humana Part D (CMS formulary file, plan-grounded).

  • growth hormone(Cigna)PA required

    Cigna Part D (CMS formulary file, plan-grounded).

  • glp1 agonists(Cigna)PA required

    Cigna Part D (CMS formulary file, plan-grounded).

  • insulins(Cigna)No PA

    Cigna Part D (CMS formulary file, plan-grounded).

  • growth hormone(Aetna)PA required

    Aetna Part D (CMS formulary file, plan-grounded).

  • insulins(Aetna)PA required

    Aetna Part D (CMS formulary file, plan-grounded).

  • glp1 agonists(Aetna)PA required

    Aetna Part D (CMS formulary file, plan-grounded).

  • insulins(Kaiser)No PA

    Kaiser Part D (CMS formulary file, plan-grounded).

  • growth hormone(Kaiser)PA required

    Kaiser Part D (CMS formulary file, plan-grounded).

  • glp1 agonists(Kaiser)PA required

    Kaiser Part D (CMS formulary file, plan-grounded).

commercial qhp
  • glp1 agonists(Molina Healthcare)PA required

    Molina Healthcare commercial formulary. Ozempic/Trulicity/Rybelsus/liraglutide all carry ST

  • insulins(Molina Healthcare)No PA

    Molina Healthcare commercial formulary. Human Insulin section only QL/MAIL/$35 cap, no PA/ST

  • growth hormone(Molina Healthcare)PA required

    Molina Healthcare commercial formulary. Growth Hormones section 4 PA flags

If denied in Washington
📨 Office of Administrative Hearings (OAH)
Unlock the full pack

Full criteria, sources & appeal paths — all 51 states.

You’ve seen the breadth and one state in full. The complete Endocrinologypack — every state’s criteria, source citations, and step-by-step appeal instructions — is one email away.

We'll never sell or share your email.

Assembled from Auth57’s rules + criteria corpus + 51-state appeal layer. Draft data — verify against the payer’s current policy before relying.